🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

9 recruiting trials

for Adebrelimab (SHR-1316)

Phase II Study of Trastuzumab Rezetecan or in Combination With Adebrelimab in HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC) NCT07241793Phase 26 sites📍 Guangzhou📍 Guangzhou📍 Guangzhou Sun Yat-sen University · Tests: Adebrelimab, Trastuzumab Rezetecan Phase Ib/II Clinical Study of Adebrelimab in Combination With Decitabine, Albumin-bound Paclitaxel, and Gemcitabine for the First-line Treatment of Metastatic Pancreatic Cancer NCT06454448Phase 1, Phase 21 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: Adebrelimab;decitabine; Phase 2 Trial of Adjuvant Adebrelimab Combined With Capecitabine in High-Risk Resected Cholangiocarcinoma: ACHIEVE NCT06607276Phase 24 sites📍 Nanjing📍 Nanjing📍 Xuzhou The First Affiliated Hospital with Nanjing Medical Universi… · Tests: Adebrelimab and capecitabine, capecitabine A Phase II Trial of Perioperative Adebrelimab Combined With XELOX in Resectable Locally Advanced Gastric/Gastroesophageal Junction Cancer (GC/GEJC) NCT06506292Phase 21 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: Adebrelimab, XELOX A Phase II Clinical Study of SHR-7787 Injection Combined With SHR-1316 Injection in Patients With LS-SCLC NCT07798947Phase 21 site📍 Jinan Shanghai Hengrui Pharmaceutical Co., Ltd. · Tests: SHR-7787 Injection, SHR-1316 A Study of Trastuzumab Rezetecan in Combination With Adebrelimab Versus Investigator's Choice of Therapy in Subjects With Residual Triple Negative Breast Cancer NCT07679360Phase 31 site📍 Beijing Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Tests: Trastuzumab Rezetecan for Injection, Adebrelimab Injection, Capecitabine tablets, Pembrolizumab injection Clinical Study on the Treatment of MIBC Patients With SHR-A2102 Injection Combined With Adebrelimab (SHR-1316) NCT06879145Phase 2, Phase 31 site📍 Shanghai Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Tests: SHR-A2102；Adebrelimab Clinical Study of Adebrelimab Therapy in the Perioperative Treatment of Gastric Cancer or Gastroesophageal Junction Cancer NCT07522151Phase 31 site📍 Beijing Shanghai Shengdi Pharmaceutical Co., Ltd · Tests: Adebrelimab plus S-1 and oxaliplatin, Adebrelimab blank preparation plus S-1 and oxaliplatin. A Single-arm, Open, Single-center Exploratory Study of Adebrelimab (SHR-1316) in Combination With Chemotherapy for the Perioperative Treatment of Locally Advanced Resectable Esophageal Squamous Carcinoma NCT06869213Phase 21 site📍 Beijing Peking University Cancer Hospital & Institute · Tests: Adebrelimab (SHR-1316) + Nab-paclitaxel + Cisplatin
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy